ApoB

Apolipoprotein B (ApoB) is a key protein in lipid metabolism that plays a crucial role in cardiovascular health by facilitating the transport of cholesterol and triglycerides through the bloodstream. Studies have consistently highlighted ApoB's importance in assessing cardiovascular risk. For instance, genetic variants affecting ApoB, such as those found in familial hypercholesterolemia, can significantly impact lipid levels and increase the risk of atherosclerosis. Additionally, a high ratio of ApoB to apolipoprotein A-1 (ApoA-1) is strongly associated with an increased risk of major adverse cardio- and cerebrovascular events, making it a valuable biomarker in clinical practice. Despite its significance, there are ongoing debates about the optimal use of ApoB measurements in routine care, with some arguing for broader adoption while others caution against overreliance on this marker. The evidence base for ApoB's role in cardiovascular health is robust but continues to evolve.

Sources

• The LDLR, APOB, and PCSK9 Variants of Index Patients with Familial Hypercholesterolemia in Russia. (PMID:33418990)
• Biosynthesis and Metabolism of ApoB-Containing Lipoproteins. (PMID:38635875)
• ApoB. (PMID:31070997)
• ApoB in clinical care: Pro and Con. (PMID:30463677)
• High apoB/apoA-1 ratio is a strong risk predictor of major adverse cardio- and cerebrovascular events part 2: a review basis for updating guidelines. (PMID:40776757)
• Apolipoprotein B: Bridging the Gap Between Evidence and Clinical Practice. (PMID:38950110)

_Worker-drafted node, Hermes writer enrichment, pending editorial review._